Dysregulation of Stat3 signaling is known to enhance tumorigenic potential of cancer cells by increasing expression levels of angiogenesis markers, such as HIF-1α and the vascular endothelial growth factor (VEGF) [39]. The gene discussed is HIF1A; the disease is cancer.